Skip to main navigation

Skip to content

Customer Service: 866-788-9007

PHYSICIAN LOGIN | CRF LOGIN

ORDER TEST

Company
Products
Research & Development
Investors
Scientific Publications
Resources

August 10, 2020 Castle Biosciences Announces Second Quarter 2020 Results

Email Alerts

Email Alerts

Required fields denoted by an asterisk ().

Alert type
Quote
SEC Filing
End of the Day SEC Filing
Event
News

Email

Latest News

Castle Biosciences Announces Second Quarter 2020 Results August 10, 2020
Castle Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference August 5, 2020
Castle Biosciences to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020 July 27, 2020
Castle Biosciences Announces Publication of Clinical Utility, Long-Term Outcomes Data and Meta-Analysis for DecisionDx-UM for Patients with Uveal Melanoma July 15, 2020
Second Systematic Review and Meta-Analysis Published Demonstrating DecisionDx-Melanoma as Independent Predictor of Recurrence, Distant Metastasis and Overall Survival in Cutaneous Melanoma July 9, 2020

Site - Investor Tools

Print Page

RSS Feeds

Email Alerts

Investor Contact

Investor Contact

Search

Connect with Us

Company

About Us
History
Leadership
- Executive Management
- Board of Directors
Licenses
Careers
Contact Us

Products

Cutaneous Melanoma
- DecisionDx-Melanoma
- DecisionDx-CMSeq
Uveal Melanoma

Research & Development

Our Approach
Tests in Development
Cutaneous Squamous Cell Carcinoma
Suspicious Pigmented Lesions

Latest News & Publications

Press Releases
Scientific Publications
Email Alerts

Resources

Healthcare Professionals
Patients

Copyright © 2020 Castle Biosciences, Inc. | All Rights Reserved

Privacy Policy
Terms of Use
Contact Us

7ads6x98y